Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
Benita S. Katzenellenbogen, Valeria Sanabria Guillen, John A. Katzenellenbogen
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions
Miaomiao Wu, Lidong Sun, Tanjing Song
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 7
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Pan-Cancer Upregulation of the FOXM1 Transcription Factor
Daniele Pozzobon, Arianna Bellezza, Federico M. Giorgi
Genes (2025) Vol. 16, Iss. 1, pp. 56-56
Open Access
A computational and structural approach to identify malignant non-synonymous FOXM1 single nucleotide polymorphisms in triple-negative breast cancer
Prarthana Chatterjee, Satarupa Banerjee
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access
Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Tsen‐Long Yang, Chung‐Hsin Tsai, Ying‐Wen Su, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 671-671
Open Access
Deciphering FOXM1 regulation: implications for stemness and metabolic adaptations in glioblastoma
Kumari Swati, Saniya Arfin, Kirti Agrawal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
High-Throughput Empirical and Virtual Screening To Discover Novel Inhibitors of Polyploid Giant Cancer Cells in Breast Cancer
Yushu Ma, Chien-Hung Shih, Jinxiong Cheng, et al.
Analytical Chemistry (2025)
Open Access
Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
Sanjeev Raghuwanshi, Andrei L. Gartel
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189015-189015
Closed Access | Times Cited: 13
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer
Alexandra N. Aquino-Acevedo, Joel A. Orengo-Orengo, Melanie E. Cruz-Robles, et al.
Cell Division (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
KHSRP has oncogenic functions and regulates the expression and alternative splicing of DNA repair genes in breast cancer MDA-MB-231 cells
Xuelaiti Paizula, Aliya Wulaying, Chen Dong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers
Natan Bar‐Chama, Bakri Elsheikh, Channa Hewamadduma, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 933-947
Open Access | Times Cited: 2
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1
Yiquan Xiong, Lan Shi, Lei Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death
Sandeep Kumar, Yvonne Ziegler, Blake N. Plotner, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 2, pp. 307-320
Open Access | Times Cited: 2
Overexpression of CDC25A, AURKB, and TOP2A Genes Could Be an Important Clue for Luminal A Breast Cancer
Murat Kaya, Asmaa Abuaısha, İlknur Süer, et al.
Meme sağlığı dergisi/Meme sağlığı dergisi (2024), pp. 284-291
Open Access | Times Cited: 2
The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer
Hui Yuan, Liang Yu, Shaorun Hu, et al.
Medicine (2024) Vol. 103, Iss. 15, pp. e37709-e37709
Open Access | Times Cited: 1
MicroRNAs role in telomere length maintenance and telomerase activity in tumor cells
Stéfanne Bortoletto, Emanuelle Nunes-Souza, Rafael Marchi, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 9, pp. 1089-1100
Closed Access | Times Cited: 1
Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers
Sayra Dilmaç, Zühal Hamurcu, Bülent Özpolat
Cancers (2024) Vol. 16, Iss. 22, pp. 3823-3823
Open Access | Times Cited: 1
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy
Ellen Voigt, Dawn E. Quelle
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13596-13596
Open Access | Times Cited: 4
Transcriptomic Integration Analyses Uncover Common Bisphenol A Effects Across Species and Tissues Primarily Mediated by Disruption of JUN/FOS, EGFR, ER, PPARG, and P53 Pathways
Renjun Yang, Yuanping Lu, Nuoya Yin, et al.
Environmental Science & Technology (2023) Vol. 57, Iss. 48, pp. 19156-19168
Closed Access | Times Cited: 3
Oncogenic role of FOXM1 in human prostate cancer (Review)
Da Lee, Jung Nyeo Chun, Insuk So, et al.
Oncology Reports (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 3
High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma
Fei Wei, Yan Yan, Guangjun Liu, et al.
PeerJ (2023) Vol. 11, pp. e16306-e16306
Open Access | Times Cited: 2
Abnormal expression of FOXM1 in carcinogenesis of renal cell carcinoma: From experimental findings to clinical applications
Yanmei Shan, Liying Zheng, Shilong Zhang, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 692, pp. 149251-149251
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top